These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
377 related articles for article (PubMed ID: 24983320)
1. Factor XIII activity mediates red blood cell retention in venous thrombi. Aleman MM; Byrnes JR; Wang JG; Tran R; Lam WA; Di Paola J; Mackman N; Degen JL; Flick MJ; Wolberg AS J Clin Invest; 2014 Aug; 124(8):3590-600. PubMed ID: 24983320 [TBL] [Abstract][Full Text] [Related]
2. Factor XIII in plasma, but not in platelets, mediates red blood cell retention in clots and venous thrombus size in mice. Kattula S; Byrnes JR; Martin SM; Holle LA; Cooley BC; Flick MJ; Wolberg AS Blood Adv; 2018 Jan; 2(1):25-35. PubMed ID: 29344582 [TBL] [Abstract][Full Text] [Related]
3. Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin α-chain crosslinking. Byrnes JR; Duval C; Wang Y; Hansen CE; Ahn B; Mooberry MJ; Clark MA; Johnsen JM; Lord ST; Lam WA; Meijers JC; Ni H; Ariëns RA; Wolberg AS Blood; 2015 Oct; 126(16):1940-8. PubMed ID: 26324704 [TBL] [Abstract][Full Text] [Related]
4. Factor XIII A-Subunit V34L Variant Affects Thrombus Cross-Linking in a Murine Model of Thrombosis. Duval C; Ali M; Chaudhry WW; Ridger VC; Ariëns RA; Philippou H Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):308-16. PubMed ID: 26743168 [TBL] [Abstract][Full Text] [Related]
6. The factor XIII-A Val34Leu polymorphism decreases whole blood clot mass at high fibrinogen concentrations. Kattula S; Bagoly Z; Tóth NK; Muszbek L; Wolberg AS J Thromb Haemost; 2020 Apr; 18(4):885-894. PubMed ID: 31989767 [TBL] [Abstract][Full Text] [Related]
7. Identification of Factor XIII β-Sandwich Residues Mediating Glutamine Substrate Binding and Activation Peptide Cleavage. Mohammed RDS; Piell KM; Maurer MC Thromb Haemost; 2024 May; 124(5):408-422. PubMed ID: 38040030 [TBL] [Abstract][Full Text] [Related]
8. Fibrinogen, red blood cells, and factor XIII in venous thrombosis. Walton BL; Byrnes JR; Wolberg AS J Thromb Haemost; 2015 Jun; 13 Suppl 1(Suppl 1):S208-15. PubMed ID: 26149026 [TBL] [Abstract][Full Text] [Related]
9. Novel venous thromboembolism mouse model to evaluate the role of complete and partial factor XIII deficiency in pulmonary embolism risk. Kattula S; Sang Y; de Ridder G; Silver AC; Bouck EG; Cooley BC; Wolberg AS J Thromb Haemost; 2021 Dec; 19(12):2997-3007. PubMed ID: 34431201 [TBL] [Abstract][Full Text] [Related]
10. The interaction between fibrinogen and zymogen FXIII-A2B2 is mediated by fibrinogen residues γ390-396 and the FXIII-B subunits. Byrnes JR; Wilson C; Boutelle AM; Brandner CB; Flick MJ; Philippou H; Wolberg AS Blood; 2016 Oct; 128(15):1969-1978. PubMed ID: 27561317 [TBL] [Abstract][Full Text] [Related]
11. Factor XIII deficiency does not prevent FeCl Tang Z; Kattula S; Holle LA; Cooley BC; Lin FC; Wolberg AS Res Pract Thromb Haemost; 2020 Jan; 4(1):111-116. PubMed ID: 31989092 [TBL] [Abstract][Full Text] [Related]
12. Factor XIII deficiency: complete phenotypic characterization of two cases with novel causative mutations. Katona É; Muszbek L; Devreese K; Kovács KB; Bereczky Z; Jonkers M; Shemirani AH; Mondelaers V; Ermens AA Haemophilia; 2014 Jan; 20(1):114-20. PubMed ID: 24118344 [TBL] [Abstract][Full Text] [Related]
13. Targeted inactivation of the mouse locus encoding coagulation factor XIII-A: hemostatic abnormalities in mutant mice and characterization of the coagulation deficit. Lauer P; Metzner HJ; Zettlmeissl G; Li M; Smith AG; Lathe R; Dickneite G Thromb Haemost; 2002 Dec; 88(6):967-74. PubMed ID: 12529747 [TBL] [Abstract][Full Text] [Related]
14. Sustained depletion of FXIII-A by inducing acquired FXIII-B deficiency. Strilchuk AW; Meixner SC; Leung J; Safikhan NS; Kulkarni JA; Russell HM; van der Meel R; Sutherland MR; Owens AP; Palumbo JS; Conway EM; Pryzdial ELG; Cullis PR; Kastrup CJ Blood; 2020 Dec; 136(25):2946-2954. PubMed ID: 32678423 [TBL] [Abstract][Full Text] [Related]
15. Evaluating the Effects of Fibrinogen αC Mutations on the Ability of Factor XIII to Crosslink the Reactive αC Glutamines (Q237, Q328, Q366). Mouapi KN; Wagner LJ; Stephens CA; Hindi MM; Wilkey DW; Merchant ML; Maurer MC Thromb Haemost; 2019 Jul; 119(7):1048-1057. PubMed ID: 31055797 [TBL] [Abstract][Full Text] [Related]
16. Newly-Recognized Roles of Factor XIII in Thrombosis. Byrnes JR; Wolberg AS Semin Thromb Hemost; 2016 Jun; 42(4):445-54. PubMed ID: 27056150 [TBL] [Abstract][Full Text] [Related]
17. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin. Siebenlist KR; Meh DA; Mosesson MW Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711 [TBL] [Abstract][Full Text] [Related]
18. Coagulation factor XIII: a multifunctional transglutaminase with clinical potential in a range of conditions. Dickneite G; Herwald H; Korte W; Allanore Y; Denton CP; Matucci Cerinic M Thromb Haemost; 2015 Apr; 113(4):686-97. PubMed ID: 25652913 [TBL] [Abstract][Full Text] [Related]
19. Antibodies against Noncatalytic B Subunit of Factor XIII Inhibit Activation of Factor XIII and Fibrin Crosslinking. Souri M; Yokoyama C; Osaki T; Ichinose A Thromb Haemost; 2023 Sep; 123(9):841-854. PubMed ID: 36934722 [TBL] [Abstract][Full Text] [Related]
20. Factor XIII Prevents Pulmonary Emboli in Mice by Stabilizing Deep Vein Thrombi. Shaya SA; Gani DM; Weitz JI; Kim PY; Gross PL Thromb Haemost; 2019 Jun; 119(6):992-999. PubMed ID: 31005064 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]